Drug discovery has traditionally been a lengthy and expensive process, involving extensive research, clinical trials, and regulatory hurdles. However, the emergence of artificial intelligence (AI) is poised to revolutionize this field, offering unprecedented efficiency in developing novel therapeutics. AI-powered tools can analyze vast datasets of

Pharmacogenomics holds immense opportunity to revolutionize drug development by evaluating the influence of an individual's genetic makeup on their sensitivity to medications. This field investigates the connection between genes and drug action, paving the way for more precise therapies. By determining genetic indicators that forecast drug outcomes